Clinical trial · Interventional
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors
NCT02452710CI-TRIAL-00036110terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study funding was completed.
Summary
Brief summary (as posted)
This research study is evaluating the usefulness of a placebo (a tablet with no active ingredients) on fatigue in cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fatigue in Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Open-Label Placebo
- description
- \- Placebo Tablets-Twice a day for 3-4 weeks
- interventionNames
- Other: Placebo
- type
- NO_INTERVENTION
- label
- NT-Control
- description
- \- No Placebo Tablets
Primary outcomes (1)
- measure
- Change in Fatigue on the Functional Assessment of Cancer Therapy - Fatigue (FACIT-F) scale
- timeFrame
- Change from baseline to Day 8, and from baseline to Day 22
- description
- 13-item self-report measure of fatigue
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer survivor, with no evidence of active disease * ≥18 years of age * ≥6 months and \<10 years post active treatment * Reports being bothered by fatigue in the past month and has a score of \<43 on FACIT-F. * Able to read and write in English Exclusion Criteria: * Being evaluated or likely to be evaluated for a medical cause of fatigue (e.g., anemia, hypothyroidism) during the study. (per provider report) * Have indications of sleep apnea as assessed by Epworth Sleepiness scale score ≥10. * Are receiving, or are likely to receive another intervention for the treatment of fatigue during the study period. (per provider report)
References
Publications (0)
Data not yet available
No reference posted for this study.